US Patent 9259459 Antibody vaccine conjugates and uses therefor
Patent 9259459 was granted and assigned to Celldex Therapeutics on February, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+323 characters)
Article
Patent abstract
The present invention provides novel antibody vaccine conjugates and methods of using the same to induce a cytotoxic T cell (CTL) response. In a particular, embodiment, the vaccine conjugate includes a human chorionic gonadotropin beta subunit (βhCG) antigen linked to an anti-mannose receptor (MR) antibody.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Lizhen He0
Michael Endres0
Tibor Keler0
Venky Ramakrishna0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09259459 Antibody vaccine conjugates and uses therefor US Patent 9259459 Antibody vaccine conjugates and uses therefor
Infobox
Patent Number
09259459
Patent Number
9259459
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09259459 Antibody vaccine conjugates and uses therefor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09259459
Date of patent
February 16, 2016
Patent application number
10903191
Date Filed
July 30, 2004
Patent primary examiner
Find more entities like US Patent 9259459 Antibody vaccine conjugates and uses therefor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
